|Venture Round, 6/07 |
Gemma Frisius Fonds
AlgoNomics is a Belgium based biotech company providing structural bioinformatics services to develop rationally designed therapeutics in the broad field of immunotherapy. AlgoNomics owns a rich, proprietary platform for structure-based protein and peptide design. The technology platform contains innovative tools to unravel protein-protein and protein-peptide interactions. AlgoNomicsâ€™ premier product is the EpibaseÂ® platform for T-cell epitope identification in different population groups, applied in the discovery of vaccines and therapeutic proteins.